Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

King Restatement Will Boost 2004 Revenue, Income But Hurt Prior Year Results

Dec 09 2004

• By The Pink Sheet Daily

Related Content

King To Set Aside Additional $65 Mil. To Settle SEC/OIG Investigation

Aug 05 2004

King's Review Of Product Returns Could Scuttle Mylan Merger

Oct 28 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window